Martine Lamfers

15PUBLICATIONS
36CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 07, 2025
Cut the fat: targeting cholesterol and lipid metabolism in glioblastoma.

Safet Zekanovic, Puspha Achaiber Sing, Sieger Leenstra

|Jan 25, 2025
Adenovirus-Neutralizing and Infection-Promoting Activities Measured in Serum of Human Brain Cancer Patients Treated with Oncolytic Adenovirus Ad5-∆24.RGD.

Ida H van der Meulen-Muileman, Joana Amado-Azevedo, Martine L M Lamfers

|Jan 08, 2025
A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for Glioblastoma.

Ioannis Ntafoulis, Stijn L W Koolen, Olaf van Tellingen

|Sep 28, 2024
BMP4 and Temozolomide Synergize in the Majority of Patient-Derived Glioblastoma Cultures.

Iris S C Verploegh, Andrea Conidi, Hoesna El Hassnaoui

|Nov 14, 2023
Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells.

Federica Fabro, Trisha V Kers, Kate J Feller

Pageof 3